Advanced Medical Solutions Group (LON:AMS) , the global medical technology company, yesterday held its annual general meeting. The company, which was founded in 1991 and supplies specialist wound dressings and healing solutions, including Silver Alginate dressings and Cyanoacrylates (glues used to seal wounds). The chairman, Dr. Geoffrey Vernon, said the company had seen a strong first half with trading substantially ahead of the same period of 2009, and inline with market expectations for the full period ending 31st December 2010. Consensus estimates for the financial year ending December 2010 are for pre-tax profit of £5.11m and eps of 3.48p.

He reported several key initiatives on which the company would focus in the near future. The company's LiquiBand (wound closure) range found three new distribution partners in addition to Cardinal Health (NYSE:CAH), the $12bn market cap US healthcare giant. The addition of the largest pharmaceutical distributor in North America gave the product coverage in non hospital sites as well as the hospital and medical practise sites. The Liquiband trademark was registered in the US, and received regulatory approval in Japan and Canada for the full product range. The company's Activheal® ( first option wound care products which promote moist wound healing) value range has been pushed to the NHS, who is looking to cut budgets, offering substantial savings to Trusts. With the move to the new facility at Winsford on schedule and on budget, the board remains positive very positive about the 2010 outlook and intends to confirm the payment of a maiden dividend for the full 2010 financial year, payable in 2010. One to support!

Unlock the rest of this article with a 14 day trial

Already have an account?
Login here